In this interview Dr Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade 34+ cells for cell and gene therapy process development.
Read more
In this interview Dr Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade 34+ cells for cell and gene therapy process development.
Read more